NCT01799590 - Continuous Treatment Study of Topiramate in Migraine Participants | Biotech Hunter

Enrollment

296

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Migraine

Interventions

DRUG

Topiramate

Topiramate tablets will be administered orally in the dose range of 50 to100 milligram per day (mg/day). Dose will be increased or decreased as per Investigator's discretion. Maximum daily dose limit will be 200 mg.

Trial Locations (25)

Unknown

Chitose

Hachiōji

Isehara

Kagoshima

Kamogawa

Kitakyushu

Kobe

Kumamoto

Kyoto

Minato

Morioka

Nagoya

Nishinomiya

Numakunai

Sagamihara

Sapporo

Shinjuku-Ku

Shizuoka

Suginami-Ku

Tokyo

Toyama

Toyonaka

Ube

Yokohama

Yonago